Skip to content

Study on cognitive improvement and mechanism of schizophrenia based on exergame therapy

Study on cognitive improvement and mechanism of schizophrenia based on exergame therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057729
Enrollment
Unknown
Registered
2022-03-16
Start date
2022-03-14
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Experimental group:Exergame
Control group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Nationality: Han nationality; 2. Aged 18-50 years; 3. Handedness: right-handed; 4. Diagnostic criteria: consistent with the diagnosis of schizophrenia in DSM-V; 5. Duration >=3 months, the type and dose of antipsychotics currently used stabilized within 8 weeks; 6. Total score of Positive and Negative Symptom Scale (PANSS) >=50 (moderate severe); 7. Montreal Cognitive Assessment Scale (MoCA) score < 26; 8. Patients or their legal guardians agreed to participate in the study and signed the informed consent form; 9. Able to cooperate to complete the experiment.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from color blindness, color weakness, deafness, stuttering and other conditions; 2. Taking immunosuppressive agents, microbiological agents, cytokines or antibiotics within the past 3 months; 3. Patients with inflammatory bowel disease and other intestinal diseases, diarrhea and abnormal stool routine examination in the last 3 months; 4. Diet has changed significantly in the past 3 months; 5. Participated in any investigational drug trial within the past 30 days; 6. Patients who are pregnant or breastfeeding or plan to become pregnant during the study period; 7. Patients with organic encephalopathy or neurological diseases or with other mental diseases; 8. Cardiopulmonary function test results are poor, very poor; 9. Patients who are not fit for exercise, such as fractures, or suffer from diseases with high risk of exercise, such as hypertension and heart disease; 10. Moderate intensity exercise for more than 100 minutes per week.

Design outcomes

Primary

MeasureTime frame
cognitive function;

Secondary

MeasureTime frame
psychiatric symptoms;sleep quality;depressive symptom;anxiety symptom;social function;cardio-pulmonary function;changes in brain structure and function;intestinal flora changes;changes of cytokines in peripheral blood;changes of hormone levels in peripheral blood;changes of related gene expression in peripheral blood;

Countries

China

Contacts

Public ContactDeng Wei
mrdengwei@163.com+86 18980605805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026